Text: H.R.5122 — 114th Congress (2015-2016)All Information (Except Text)

There is one version of the bill.

Text available as:

Shown Here:
Introduced in House (04/29/2016)


114th CONGRESS
2d Session
H. R. 5122


To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.


IN THE HOUSE OF REPRESENTATIVES

April 29, 2016

Mr. Bucshon (for himself, Mr. Dold, Mr. Boustany, Mr. Tom Price of Georgia, and Mr. Shimkus) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned


A BILL

To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Prohibition of further action on proposed rule regarding testing of Medicare part B prescription drug models.

The Secretary of Health and Human Services may not take any action to finalize, implement, or enforce the proposed rule entitled “Medicare Program; Part B Drug Payment Model” (81 Fed. Reg. 13230 (March 11, 2016)).